# Neumora Posts $0.18 Q3 GAAP Loss Per Share and $85.7 Million in Cash

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/58395
Published: 2026-11-16T13:40:20.000Z
Updated: 2026-11-16T13:40:20.000Z
Section: Business

> Cash and cash equivalents totaled $85.7 million as of Sept. 30, 2026. The company provided no updated financial runway guidance.

Neumora Therapeutics, Inc. posted a GAAP loss of $0.18 per share for the third quarter of 2026, with cash and cash equivalents totaling $85.7 million as of Sept. 30.

The company provided no updated financial runway guidance.


